On Thursday, Agnico Eagle Mines Ltd (USA)(NYSE:AEM)’s shares inclined 2.82% to $28.43.
Agnico Eagle Mines Limited (AEM) report additional results from the 2015 Phase 1 exploration program at the Amaruq gold project in Nunavut, northern Canada. The Company last stated results from this project in its news release dated April 30, 2015. The Company is also reporting its initial drill results from the El Barqueno project in west-central Mexico, which was attained in November 2014. In addition, the acquisition of Soltoro Ltd. has closed.
Highlights comprise:
Drilling at Amaruq has filled in the gap under Whale Lake with noteworthy gold grades and good widths - Drilling at Whale Tail under Whale Lake continued to intersect high-grade gold over noteworthy widths, counting 19.8 grams per tonne (“g/t”) gold (capped) over 5.0 meters at 130 meters depth (hole AMQ15-187), and 15.9 g/t gold (capped) over 14.6 meters at 126 meters depth (hole AMQ15-181)
New gold structure confirmed north of Whale Tail deposit at Amaruq - New mineralized structure about 100 meters north of the Whale Tail deposit, counting 6.1 g/t gold (capped) over 4.0 meters at 284 meters depth and 9.7 grams g/t gold (capped) over 3.8 meters at 306 meters depth (hole AMQ15-177).
El Barqueno - Azteca and Angostura mineralization extended by drilling - Infill drilling at Azteca yielded 4.02 g/t gold, 4.01 g/t silver and 0.03% copper (uncapped) over 12.2 metres at 31 meters depth (hole BDD0119). Angostura is being extended to the southwest and deeper, counting the BRQ15-153 intercept of 1.93 g/t gold, 5.84 g/t silver and 0.04% copper (uncapped) over 5.9 meters at 217 meters below surface.
El Barqueno - Pe a de Oro prospect extended to southwest by drilling - Hole BRQ15-148 intersected 3.95 g/t gold, 15.65 g/t silver and 1.34% copper (uncapped) over 9.6 meters at 135 meters below surface, suggesting continuity of mineralization to the southwest.
Agnico Eagle Mines Limited engages in the exploration, development, and production of mineral properties. It primarily explores for gold, in addition to for silver, copper, zinc, and lead. The company’s flagship property comprises the LaRonde mine, which comprises a 100% owned LaRonde property that comprises of 36 contiguous mining claims and 1 provincial mining lease covering 1,047.4 hectares; El Coco property, which comprises 22 contiguous mining claims and 1 provincial mining lease comprising 356.7 hectares; and Terrex property that comprises 21 mining claims and 1 provincial mining lease covering 424.4 hectares, in addition to 3 surface rights leases covering in total of about 303.6 hectares in northwestern Quebec.
Parkway Properties Inc (NYSE:PKY)’s shares gained 1.71% to $17.86.
Parkway Properties, Inc. (PKY) declared that it will release 2015 second quarter earnings on Monday, August 3, 2015 after the market close and will hold its second quarter conference call on Tuesday, August 4, 2015 at 9:00 a.m. Eastern Time. The Company’s earnings release and supplemental information package will be posted to the Company’s website prior to the conference call.
Parkway Properties, Inc., a real estate investment trust (REIT), engages in the operation, acquisition, ownership, administration, and leasing of office properties. It operates and invests principally in office properties in the southeastern and southwestern United States and Chicago.
At the end of Thursday’s trade, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)‘s shares dipped -0.81% to $8.58.
Achillion Pharmaceuticals, Inc. (ACHN) the Company’s stockholders approved the Company’s 2015 Stock Incentive Plan (the “2015 Plan”). The 2015 Plan replaced the Company’s 2006 Stock Incentive Plan, as amended (the “2006 Plan”). Upon the approval of the 2015 Plan by stockholders, the 2006 Plan terminated, and all then outstanding awards under the 2006 Plan will remain in effect, but no additional awards will be made under the 2006 Plan. However, the terms of the 2006 Plan will continue to apply to awards formerly granted under the 2006 Plan.
The 2015 Plan allows for the issuance of 6,900,000 new shares of common stock plus up to 1,894,444 shares of common stock that remained accessible for issuance under the formerly approved 2006 Plan right away prior to the effectiveness of the 2015 Plan, all of which shares rolled over and became accessible for issuance under the 2015 Plan upon its effectiveness. Solely to the extent that any of the 8,726,686 shares of common stock subject to awards that were issued and outstanding under the 2006 Plan right away prior to the effectiveness of the 2015 Plan expire, terminate, are surrendered, cancelled or forfeited, such shares also will become accessible for the future grant of awards under the 2015 Plan. All of the foregoing share numbers are subject, in the case of incentive stock options, to any limitations under the Internal Revenue Code of 1986, as amended (the “Code”), and are also subject to adjustment upon stock splits, stock dividends, and other specified events. Certain sub-limitations apply to the shares accessible for issuance under the 2015 Plan. The 2015 Plan allows for the issuance of incentive stock options intended to qualify under Section 422 of the Code, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock units and other stock-based awards. The maximum number of shares with respect to which awards may be granted to any participant under the 2015 Plan may not exceed 1,500,000 shares per fiscal year (subject to adjustment upon stock splits, stock dividends, and other specified events). The maximum aggregate number of shares with respect to which awards may be granted to directors who are not employees of the Company at the time of grant will be 10% of the maximum number of shares authorized for issuance under the 2015 Plan.
The material terms of the 2015 Plan are summarized on pages 18 through 27 of the Company’s definitive proxy statement on Plan 14A filed with the Securities and Exchange Commission (the “SEC”) on April 17, 2015, which description is attached hereto as exhibit 99.1 and incorporated herein by reference. The description of the 2015 Plan is qualified in its entirety by reference to the full text of the 2015 Plan, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on developing combination therapies for the treatment of chronic hepatitis C (HCV) infection and drug-resistant bacterial infections
SL Green Realty Corp (NYSE:SLG), ended its Thursday’s trading session with 0.91% gain, and closed at $112.74.
SL Green Realty Corp. (SLG) stated that its board of directors has declared the quarterly dividend of $0.60 per share of common stock. The dividend is payable on July 15, 2015 to shareholders of record at the close of business on June 30, 2015.
The board of directors also declared the regular quarterly dividend on the company’s Series I Preferred Stock for the period April 15, 2015 through and counting July 14, 2015, of $0.40625 per share, which is the equivalent of an annualized dividend of $1.625 per share. The dividend will be payable July 15, 2015 to shareholders of record at the close of business on June 30, 2015.
SL Green Realty Corp. is a real estate investment trust (REIT). The firm engages in the property administration, acquisitions, financing, development, construction, and leasing. It also provides tenant services to its clients. The firm invests in real estate markets of the United States. It primarily invests in commercial office and retail properties. SL Green Realty Corp. was founded in 1970 and is based in New York, New York.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
